why Precigen Inc [PGEN] is a Good Choice for Investors After New Price Target of $8.25

NFLX Stock

Precigen Inc [NASDAQ: PGEN] slipped around -0.03 points on Tuesday, while shares priced at $4.13 at the close of the session, down -0.72%.

Precigen Inc stock is now 330.66% up from its year-to-date (YTD) trading value. PGEN Stock saw the intraday high of $4.2487 and lowest of $4.02 per share. The company’s 52-week high price is 5.22, which means current price is +300.97% above from all time high which was touched on 09/03/25.

Compared to the average trading volume of 7.62M shares, PGEN reached a trading volume of 5734457 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Precigen Inc [PGEN]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PGEN shares is $8.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PGEN stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for Precigen Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 15, 2025. The new note on the price target was released on March 22, 2024, representing the official price target for Precigen Inc stock.

How has PGEN stock performed recently?

Precigen Inc [PGEN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.24. With this latest performance, PGEN shares gained by 132.02% in over the last four-week period, additionally plugging by 133.33% over the last 6 months – not to mention a rise of 268.75% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PGEN stock in for the last two-week period is set at 64.61, with the RSI for the last a single of trading hit 0.36, and the three-weeks RSI is set at 0.31 for Precigen Inc [PGEN]. The present Moving Average for the last 50 days of trading for this stock 2.52, while it was recorded at 4.39 for the last single week of trading, and 1.65 for the last 200 days.

Precigen Inc [PGEN]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Precigen Inc [PGEN] shares currently have an operating margin of -2176.31% and a Gross Margin at -30.02%. Precigen Inc’s Net Margin is presently recorded at -2868.66%.

Precigen Inc (PGEN) Capital Structure & Debt Analysis

Precigen Inc (PGEN) Efficiency & Liquidity Metrics

Precigen Inc (PGEN) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Precigen Inc. (PGEN) effectively leverages its workforce, generating an average of -$870629.37 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.71% and a Quick Ratio of 2.71%, indicating strong ability to cover short-term liabilities.

Earnings analysis for Precigen Inc [PGEN]

With the latest financial reports released by the company, Precigen Inc posted -0.09/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PGEN.

Insider trade positions for Precigen Inc [PGEN]

There are presently around $66.81%, or 74.62%% of PGEN stock, in the hands of institutional investors. The top three institutional holders of PGEN stocks are: PATIENT CAPITAL MANAGEMENT, LLC with ownership of 18.17 million shares, which is approximately 7.2017%. BLACKROCK INC., holding 10.25 million shares of the stock with an approximate value of $$16.19 million in PGEN stocks shares; and BLACKROCK INC., currently with $$10.68 million in PGEN stock with ownership which is approximately 2.6784%.

Most Popular

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.